Delivery Order SPE2DB22D2007-SPE2DB24FJ0HF
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $10,286.56, is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,832.12, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a potential value of $3,526.51 and a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,568.07 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The contract has a completion date of February 13, 2024 and a potential value of $6,504.85. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA with a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,636.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S. This contract, with a completion date of March 6, 2024, is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,805.82 firm fixed price contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,884.83 firm fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a Firm Fixed Price and a Ceiling Value of $11,790.20. The contract has a period of performance through June 4, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a Delivery Order federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,025.59, is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price type with a performance period through January 31, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...